1887

Abstract

A mouse model incorporating the epitheliotropic nature of human papillomavirus (HPV) infections has been used to study an immune response to HPV type 16 (HPV-16) E6 protein Using a transplantation technique, a novel immortal keratinocyte cell line expressing the E6 protein has been grafted onto syngeneic mice to re-form a differentiated epithelium overlying a granulation tissue bed. By this approach the presentation of viral antigens to the immune system can be modelled in a way analogous to the natural infection. Here we report a delayed-type hypersensitivity (DTH) reaction in grafted mice challenged intradermally with a recombinant vaccinia virus expressing the HPV-16 E6 protein. The specificity of the response was confirmed by the absence of a DTH reaction to challenge with virus expressing either HPV-16 E7 or L1 protein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-1-165
1994-01-01
2022-05-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/1/JV0750010165.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-1-165&mimeType=html&fmt=ahah

References

  1. Aiba S., Rokugo M., Tagami T. 1986; Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts. Cancer 58:1246–1251
    [Google Scholar]
  2. Alloub M., Barr B., Mclaren K., Smith I., Bunney M., Smart G. 1989; Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. British Medical Journal 298:153–156
    [Google Scholar]
  3. Chen L., Mizuno M., Singhal M., Hu S., Galloway D., Hellstrom I., Hellstrom K. 1992; Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. Journal of Immunology 148:2617–2621
    [Google Scholar]
  4. Cubie H., Norval M., Crawford L., Banks L., Crook T. 1989; Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia. Epidemiology and Infection 103:625–632
    [Google Scholar]
  5. Dillner J. 1990; Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. International Journal of Cancer 46:703–711
    [Google Scholar]
  6. Fierlbeck G., Schiebel U., Muller C. 1989; Immunohistology of genital warts in different stages of regression after therapy with interferon gamma. Dermatologica 179:191–195
    [Google Scholar]
  7. Ghosh A. K., Smith N. K., Stacey S. N., Glew S. S., Connor M. E., Arrand J. R., Stern P. I. 1993; Serological responses to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer. International Journal of Cancer 53:591–596
    [Google Scholar]
  8. Greenberg J. H., Smith T., Katz R. 1973; Verrucae vulgaris rejection.A preliminary study of contact dermatitis and cellular immunity response. Archives of Dermatology 107:580–582
    [Google Scholar]
  9. Halbert C. L., Demers G., Galloway D. 1991; The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. Journal of Virology 65:473–478
    [Google Scholar]
  10. Hopfl R., Sandbichler M., Sepp N., Heim K., Muller-Holzner E., Wartusch B., Dapunt O., Jochmus-Kudielka I., ter Meulen J., Gissmann L., Fritsch P. 1991; Skin test for HPV type 16 proteins in cervical intraepithelial neoplasia. Lancet 337:373–374
    [Google Scholar]
  11. Jenison S., Yu X., Valentine J., Koutsky L., Christiansen A., Beckmann A., Galloway D. 1990; Evidence of prevalent genital type human papillomavirus infections in adults and children. Journal of Infectious Diseases 162:60–69
    [Google Scholar]
  12. Jochmus-Kudielka I., Schneider A., Braun R., Kimmig R., Koldovsky U., Schneweis K., Seedorf K., Gissmann L. 1989; Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti E7 reactivity with cervical cancer. Journal of the National Cancer Institute 81:1698–1704
    [Google Scholar]
  13. Kent C., Samuel M., Winkelstein W. 1987; The role of anal/genital warts in HIV infection. Journal of the American Medical Association 258:3385–3386
    [Google Scholar]
  14. Lutzner M. A., Orth G., Dutronquay V., Ducasse M.-F., Kreis H., Crosnier J. 1983; Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet ii:422–424
    [Google Scholar]
  15. Mclean C. S., Sterling J. S., Mowat J., Nash A. A., Stanley M. A. 1993; Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. Journal of General Virology 74:239–245
    [Google Scholar]
  16. Mann V., de Lao S., Brenes M., Brinton L., Rawls J., Green M., Reeves W., Rawls W. 1990; Occurrence of IgA and IgG antibodies to select peptids representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Research 50:7815–7819
    [Google Scholar]
  17. Meneguzzi G., Cerni C., Kieny M., Lathe R. 1991; Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology 181:62–69
    [Google Scholar]
  18. Mullen D., Silverberg S., Penn I., Hammond W. 1976; Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 37:729–734
    [Google Scholar]
  19. Muller M., Viscidi R., Sun Y., Guerrero E., Hill P., Shah F., Bosch F., Munoz N., Gissmann L., Shah K. 1992; Antibodies to HPV 16 E6 and E7 proteins as markers for HPV 16 associated invasive cervical cancer. Virology 187:508–514
    [Google Scholar]
  20. Sillman F., Stanek A., Sedlis A., Rosenthal J., Lanks K., Buchhagen D., Nicastri A., Boyce J. 1984; The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. American Journal of Obstetrics and Gynecology 150:300–308
    [Google Scholar]
  21. Stacey S. N., Bartholomew J. S., Ghosh A., Stern P. L., Mackett M., Arrand J. R. 1992; Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera. Journal of General Virology 73:2337–2345
    [Google Scholar]
  22. Stauss H., Davies H., Sadovnikova E., Chain B., Horowitz N., Sinclair C. 1992; Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. Proceedings of the National Academv of Sciences, U.S.A 89:7871–7875
    [Google Scholar]
  23. Strang G., Hickling J. K., Mcindoe G. A. J., Howland K., Wilkinson D., Ikeda H., Rothbard J. 1990; Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and vims type specificity. Journal of General Virology 71:423–431
    [Google Scholar]
  24. Thivolet J., Hegazy M., Viac J. 1977; An in vivo study of cell-mediated immunity in human warts. Preliminary results. Acta dermato-venereologica 57:317–319
    [Google Scholar]
  25. Viac J., Thivolet J., Chardonnet Y. 1977; Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. British Journal of Dermatology 97:365–370
    [Google Scholar]
  26. Weissman B. E., Aaronson S. 1983; BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocyte lines. Cell 32:599–606
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-1-165
Loading
/content/journal/jgv/10.1099/0022-1317-75-1-165
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error